| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/19/2006 | EP0873355B1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/19/2006 | CN1760203A Antibacterial tripeptides and modified chemicals, and application |
| 04/19/2006 | CN1252020C Process for producing cinnamylaldehyde derivatives, use thereof and the like |
| 04/18/2006 | US7030265 Retinol derivatives, the method of preparations and the uses thereof |
| 04/18/2006 | US7030239 Compounds to treat Alzheimer's disease |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030214 Ureins derived from α, ω, diamino acids and process for their preparation |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7030161 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030085 Thiopeptide compounds |
| 04/18/2006 | US7030081 Muteins of the Ser-Cys-Asn-Thr-Ala-Thr-Cys sequence from the N- terminal 1-7 fragment of the CGRP (calcitonin gene related peptide), activates neuronal nicotinic receptor, therefor useful for therapy of neurological disorders |
| 04/18/2006 | US7029695 Therapeutic compositions containing glutathione analogs |
| 04/18/2006 | US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 04/13/2006 | WO2006039527A1 Macrocyclic sh2 domain binding inhibitors |
| 04/13/2006 | WO2006037775A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 04/13/2006 | US20060079462 Organoselenium compounds for cancer chemoprevention |
| 04/13/2006 | US20060079455 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 04/13/2006 | US20060078554 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 04/13/2006 | CA2582908A1 Macrocyclic sh2 domain binding inhibitors |
| 04/13/2006 | CA2581564A1 Compounds that modulate trh actions |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | EP1644403A2 Cytotoxic depsipeptides |
| 04/12/2006 | EP1644322A1 Aspartyl protease inhibitors |
| 04/12/2006 | EP1485346A4 Novel positively charged lipids and liposomes comprising the positively charged lipids |
| 04/12/2006 | EP1207873A4 Methods of inhibiting osteoclast activity |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1087981B1 Prenyl transferase inhibitors |
| 04/12/2006 | EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 04/12/2006 | EP0866878B1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 04/12/2006 | CN1250735C Method for production of non-proteinogen L-amino acid by fermentation |
| 04/12/2006 | CN1250722C Method for secretion and prodn. of protein |
| 04/12/2006 | CN1250532C Process for preparation of oxo-oxazoline or alloamino acid derivatives |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026450 Ma family polypeptides and anti-Ma antibodies |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026297 Neuroprotective agents |
| 04/11/2006 | US7026289 Method and compositions for treating hyperlipidemia and other conditions |
| 04/11/2006 | US7026280 Polypeptides; nervous system, brain disorders |
| 04/11/2006 | US7026003 Processes for preparing an aspartame slurry |
| 04/11/2006 | US7025961 Anti-plasmodium composition and methods of use |
| 04/11/2006 | CA2217030C Protease inhibiting succinic acid derivatives |
| 04/06/2006 | WO2006037133A1 Treatment of traumatic or degenerative neurologic, otologic, or ophthalmologic diseases with targeted protease inhibitors |
| 04/06/2006 | WO2006035937A1 Process for production of (1,3-disubstituted indolyl)- urea derivatives, intermediates therefor, and process for production of the intermediates |
| 04/06/2006 | WO2006035936A1 Par-2 antagonists |
| 04/06/2006 | WO2005061452A8 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 04/06/2006 | WO2005051799A3 Peptide increasing fusiogenic capacity of a gamete |
| 04/06/2006 | CA2581527A1 Antibacterial amide macrocycles iv |
| 04/05/2006 | EP1641816A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 04/05/2006 | EP1641814A1 New process for the production of melagatran |
| 04/05/2006 | EP1641754A1 Process and intermediates for the preparation of (1r, 2s, 5s)-3- azabicyclo[ 3, 1, 0]hexane-2-carboxamide, n- [3-amino -1-(cyclobutylmethyl)-2, 3-dioxopropyl] ]-3- [ (2s)- 2-[[[1, 1-dimethylethyl ]amino]carbonyla mino ]-3, 3-dimethyl-1-oxobutyl] -6, 6-dimethyl |
| 04/05/2006 | EP1531852A4 Caspase 9 activation and uses therefor |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1042963B1 Granular sweetener |
| 04/05/2006 | CN1756765A Metastin derivatives and their use |
| 04/05/2006 | CN1756758A Novel cantharidimide and norcantharidimide derivant and its application in medicine |
| 04/05/2006 | CN1248733C Tie2 receptor-induced gene transfer system for treating target tumor genes |
| 04/04/2006 | US7022676 obtained by hydrolysis of casein; hypotensive agentsl; for use in foods and drugs |
| 03/30/2006 | WO2005105827A3 Compounds for proteasome enzyme inhibition |
| 03/30/2006 | WO2004089297A3 Compounds and methods for treatment of thrombosis |
| 03/30/2006 | US20060069058 Beta-sheet breaker peptide analogs that inhibit beta-pleated sheet formation in amyloid beta-peptide |
| 03/30/2006 | US20060069038 Irreversible caspase-3 inhibitors as active site probes |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060069028 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 03/30/2006 | US20060068457 Substrates for tafi (a) |
| 03/30/2006 | DE102005014240A1 Antibakterielle Amid-Makrozyklen IV Antibacterial amide macrocycles IV |
| 03/29/2006 | EP1640380A1 Histone deacetylase inhibitor and process for producing the same |
| 03/29/2006 | EP1639004A1 Fluorescein-labelled peptides |
| 03/29/2006 | EP1487997A4 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
| 03/29/2006 | EP1064300A4 Peptide turn mimetics |
| 03/29/2006 | EP1036090B1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 03/29/2006 | EP0973518B1 Semi-synthetic studies toward didemnin analogues |
| 03/29/2006 | CN1753908A Novel glycopeptide or peptide capable of imparting rich taste and method of imparting rich taste to food therewith |
| 03/29/2006 | CN1753907A Method for synthesis of (2s,3as,7as)-1-((s)-alanyl)-octahydro-1h-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril |
| 03/29/2006 | CN1753906A Process for the synthesis of perindopril and its pharmaceutically acceptable salts |
| 03/28/2006 | USRE39048 substitution of the sixth amino acid Glycine of the LHRH (luteinizing hormone releasing hormone) decapeptide by D-Lysine or D-Glutamine; the resulting variant peptide is coupled to a common carrier and/or mild adjuvant; immunocastration; mammals |
| 03/28/2006 | US7019118 Antiinflammatory agents; rheumatic disease |
| 03/28/2006 | US7019023 Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 03/28/2006 | US7018981 Gastrointestinal disorders |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2252229C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 03/23/2006 | WO2006031330A2 METHOD OF REDUCING THE EFFECTS OF Aβ AND COMPOSITIONS THEREFORE |
| 03/23/2006 | WO2006031226A1 Region of factor ixa protease domain that interacts with factor viiia and methods therefor |
| 03/23/2006 | WO2005121354A3 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 03/23/2006 | WO2005116643A3 Identification of compounds modifying a cellular response |
| 03/23/2006 | US20060063941 Perindopril |
| 03/23/2006 | US20060063916 Process for preparing macrocyclic HCV protease inhibitors |
| 03/23/2006 | US20060063915 Cyclizing a diene, e.g., an N-(alk-omega-en-1-oxo-), 2-(ethylene-((alkoxycarbonyl)cyclopropylene)-iminocarbonyl-)proline, in the presence of a ruthenium catalyst in aorganic solvent in a gaseous fluid at supercritical conditions to obtain highmolecular weight macrocyclic products; antihepatitus C virus |
| 03/23/2006 | US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/23/2006 | US20060063717 Novel inhibitor of beta amyloid cleavage |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | DE4007605B4 SDK-Peptide, Verfahren zu ihrer Herstellung und diese enthaltende therapeutischen Zusammensetzungen SDK peptides, process for their preparation and therapeutic compositions containing |
| 03/23/2006 | CA2576768A1 Method of reducing the effects of a.beta. and compositions therefore |
| 03/22/2006 | EP1636253A1 Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |
| 03/22/2006 | EP1636252A1 Statine derivatives for the treatment of alzheimer s disease |
| 03/22/2006 | EP1636196A1 Novel lactams and uses thereof |
| 03/22/2006 | EP1635866A2 Modified antiviral peptides with increased activity and cell membrane affinity |
| 03/22/2006 | EP1635858A2 Targeted delivery to legumain-expressing cells |
| 03/22/2006 | EP1635816A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |